Lv12
35 积分 2021-08-24 加入
Extracellular targeted protein degrader removes antibodies in first test in humans
2小时前
待确认
SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs
20小时前
已完结
The vedotin antibody-drug conjugate payload drives platform-based nonclinical safety and pharmacokinetic profiles
25天前
已完结
Next steps for targeted protein degradation
1个月前
已完结
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models
1个月前
已完结
Aggregate-selective removal of pathological tau by clustering-activated degraders
1个月前
已完结
Bifunctional Compounds as Molecular Degraders for Integrin-Facilitated Targeted Protein Degradation
1个月前
已完结
BDTX-1535, a fourth generation EGFR inhibitor, targeting intrinsic and acquired resistance mutations in NSCLC
1个月前
已完结
Transferrin Receptor Targeting Chimeras (TransTACs) for Membrane Protein Degradation
2个月前
已完结
New ADCs bring new questions in EGFR NSCLC and beyond
2个月前
已完结
皖公网安备34019202002308
